GlobeNewswire
Iridex Announces New Thermal Dynamics Study That Strengthens Clinical Foundation and Market Potential of MicroPulse® Technology and Continuous-Wave Laser for Glaucoma Treatment
📈
AI Sentiment
Highly Positive
8/10
- Home
- IRIX
IRIX
IRIDEX Corporation
as of 12-09-2025 10:25am EST
$0.92
$0.00
-0.50%
IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.
Chart Type:
Time Range:
| Founded: | 1989 | Country: | United States |
| Employees: | N/A | City: | MOUNTAIN VIEW |
| Market Cap: | 20.2M | IPO Year: | 1996 |
| Target Price: | N/A | AVG Volume (30 days): | 105.2K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.30 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.78 - $1.89 | Next Earning Date: | 11-11-2025 |
| Revenue: | $50,647,000 | Revenue Growth: | 4.58% |
| Revenue Growth (this year): | 9.61% | Revenue Growth (next year): | N/A |
AI-Powered IRIX Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 18 hours ago
AI Recommendation
hold
Model Accuracy: 77.08%
77.08%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of IRIDEX Corporation (IRIX)
Dizon Romeo R
Buy
Chief Financial Officer
IRIX Dec 2, 2025
Avg Cost/Share
$0.94
Shares
1,584
Total Value
$1,498.40
Owned After
90,320
Dizon Romeo R
Buy
Chief Financial Officer
IRIX Nov 20, 2025
Avg Cost/Share
$0.96
Shares
5,760
Total Value
$5,529.60
Owned After
90,320
SEC Form 4
Dizon Romeo R
Buy
Chief Financial Officer
IRIX Nov 19, 2025
Avg Cost/Share
$0.96
Shares
1,000
Total Value
$960.00
Owned After
90,320
SEC Form 4
Dizon Romeo R
Buy
Chief Financial Officer
IRIX Nov 18, 2025
Avg Cost/Share
$0.94
Shares
2,133
Total Value
$2,005.02
Owned After
90,320
SEC Form 4
Dizon Romeo R
Buy
Chief Financial Officer
IRIX Nov 17, 2025
Avg Cost/Share
$0.96
Shares
3,124
Total Value
$2,998.76
Owned After
90,320
MOORE WILLIAM M
Buy
Director
IRIX Nov 17, 2025
Avg Cost/Share
$0.97
Shares
21,843
Total Value
$21,087.23
Owned After
250,674
SEC Form 4
Dizon Romeo R
Buy
Chief Financial Officer
IRIX Nov 14, 2025
Avg Cost/Share
$0.88
Shares
14,769
Total Value
$12,996.72
Owned After
90,320
SEC Form 4
MOORE WILLIAM M
Buy
Director
IRIX Nov 14, 2025
Avg Cost/Share
$0.97
Shares
28,157
Total Value
$27,244.71
Owned After
250,674
SEC Form 4
Dizon Romeo R
Buy
Chief Financial Officer
IRIX Sep 12, 2025
Avg Cost/Share
$1.37
Shares
1,450
Total Value
$1,974.50
Owned After
90,320
Dizon Romeo R
Buy
Chief Financial Officer
IRIX Sep 11, 2025
Avg Cost/Share
$1.35
Shares
1,250
Total Value
$1,682.20
Owned After
90,320
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Dizon Romeo R | IRIX | Chief Financial Officer | Dec 2, 2025 | Buy | $0.94 | 1,584 | $1,498.40 | 90,320 | |
| Dizon Romeo R | IRIX | Chief Financial Officer | Nov 20, 2025 | Buy | $0.96 | 5,760 | $5,529.60 | 90,320 | |
| Dizon Romeo R | IRIX | Chief Financial Officer | Nov 19, 2025 | Buy | $0.96 | 1,000 | $960.00 | 90,320 | |
| Dizon Romeo R | IRIX | Chief Financial Officer | Nov 18, 2025 | Buy | $0.94 | 2,133 | $2,005.02 | 90,320 | |
| Dizon Romeo R | IRIX | Chief Financial Officer | Nov 17, 2025 | Buy | $0.96 | 3,124 | $2,998.76 | 90,320 | |
| MOORE WILLIAM M | IRIX | Director | Nov 17, 2025 | Buy | $0.97 | 21,843 | $21,087.23 | 250,674 | |
| Dizon Romeo R | IRIX | Chief Financial Officer | Nov 14, 2025 | Buy | $0.88 | 14,769 | $12,996.72 | 90,320 | |
| MOORE WILLIAM M | IRIX | Director | Nov 14, 2025 | Buy | $0.97 | 28,157 | $27,244.71 | 250,674 | |
| Dizon Romeo R | IRIX | Chief Financial Officer | Sep 12, 2025 | Buy | $1.37 | 1,450 | $1,974.50 | 90,320 | |
| Dizon Romeo R | IRIX | Chief Financial Officer | Sep 11, 2025 | Buy | $1.35 | 1,250 | $1,682.20 | 90,320 |
Latest IRIDEX Corporation News
IRIX Breaking Stock News: Dive into IRIX Ticker-Specific Updates for Smart Investing
GlobeNewswire
Iridex to Present at the Sidoti Year-End Virtual Investor Conference
📊
AI Sentiment
Positive
7/10
Argus Research
Daily – Vickers Top Insider Picks for 12/02/2025
Compare IRIX vs Leading Stocks
See how IRIX stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "IRIX IRIDEX Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.